Martin & Sloan (1986). Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens. Pharmacology, Biochemistry and Behavior.
Nichols et al. (1986). Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats. Journal of Medicinal Chemistry.
Rasmussen et al. (1986). Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT 2 binding affinity. European Journal of Pharmacology.
Rasmussen & Aghajanian (1986). Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT 2 antagonists. Brain Research.
Schlemmer & Davis (1986). A primate model for the study of hallucinogens. Pharmacology, Biochemistry and Behavior.
Trulson (1986). Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats. Pharmacology, Biochemistry and Behavior.
Gomez-Jeria et al. (1987). [A quantum-chemical and experimental study of the hallucinogen (±)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane (DON).] European Journal of Medicinal Chemistry.
Grinspoon & Bakalar (1986). Can drugs be used to enhance the psychotherapeutic process? American Journal of Psychotherapy.
Mokler et al. (1987). The effects of intracranial administration of hallucinogens on operant behavior in the rat. II. 2,5-Dimethoxy-4-methylamphetamine (DOM). Pharmacology, Biochemistry and Behavior.
Lyon et al. (1988). Indolealkylamine analogs share 5-HT 2 binding characteristics with phenylalkylamine hallucinogens. European Journal of Pharmacology.
Richter et al. (1988). Electrochemical study of the hallucinogen (±)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane. The Analyst.
Smith (1988). Evolving ethics in psychedelic drug taking. Journal of Drug Issues.
Carvey et al. (1989). LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig. Progress in Neuropsychopharmacology & Biological Psychiatry.
Clifford et al. (1989). Discerning the epidemiology of drug use among a sample of college students. Journal of Drug Education.
Mckenna et al. (1989). Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [ 125I]LSD and [ 125I]DOI, a new psychotomimetic radioligand. Brain Research.
Beauchamp (1990). Island: Aldous Huxley's psychedelic utopia. Utopian Studies.
Parrish & Padua (1990). Hallucinogen abuse among an adolescent drug rehabilitation population. Journal of Adolescent Health Care.
Teitler (1990). Receptor pharmacology of MDMA and related hallucinogens. Annals of the New York Academy of Sciences.
Van Woerkom (1990). The major hallucinogens and the central cytoskeleton: An association beyond coincidence? Towards sub-cellular mechanisms in schizophrenia. Medical Hypotheses.
Bache (1991). Mysticism and psychedelics: The case of the dark night. Journal of Religion and Health.
Tart (1991). Influences of previous psychedelic drug experiences on students of Tibetan Buddhism: A preliminary exploration. Journal of Transpersonal Psychology.
Winkelman (1991). Therapeutic effects of hallucinogens. Anthropology of Consciousness.
Martin, Clifford & Clapper (1992). Patterns and predictors of simultaneous and concurrent use of alcohol, tobacco, marijuana, and hallucinogens in first-year college students. Journal of Substance Abuse.
Yamazaki, Ono & Nagao (1992). Stimulatory and inhibitory effects of serotonergic hallucinogens on spinal mono-and polysynaptic reflex pathways in the rat. Neuropharmacology.
Morstyn (1993). Time Foran RANZCP Committee for the investigation of psychedelic therapies? Australasian Psychiatry.
Werner (1993). Hallucinogens. Pediatrics in Review.
Bennet & Alarcon (1994). [Osteophloeum platyspermum and Virola duckei (Myristicaceae): newly reported as hallucinogens from Amazonian Ecuador.] Economic Botany.
Fawcett (1994). Stimulants, hallucinogens, and the generation gap. Psychiatric Annals.
Millman & Beeder (1994). The new psychedelic culture: LSD, ecstasy, "rave" parties and The Grateful Dead. Psychiatric Annals.
Nishith, Mueser & Gupta (1994). Personality and hallucinogen abuse in a college population from India. Personality and Individual Differences.
Riedlinger & Riedlinger (1994). Psychedelic and entactogenic drugs in the treatment of depression. Journal of Psychoactive Drugs.
Weil & Davis (1994). Bufo alvarius: a potent hallucinogen of animal origin. Journal of Ethnopharmacology.
Cuomo et al. (1995). Increasing use of “ecstasy“ (MDMA) and other hallucinogens on a college campus. Journal of American College Health.
Jenks (1995). An analysis of risk reduction among organized groups that promote marijuana and psychedelic drugs. Journal of Drug Issues.
Mckenna (1995). Plant hallucinogens: springboards for psychotherapeutic drug discovery. Behavioural Brain Research.
Rudgley (1995). The archaic use of hallucinogens in Europe: an archaeology of altered states. Addiction.
Abraham, Aldridge & Gogia (1996). The psychopharmacology of hallucinogens. Neuropsychopharmacology.
Chilcoat & Schütz (1996). Age-specific patterns of hallucinogen use in the US population: an analysis using generalized additive models. Drug and Alcohol Dependence.
De Smet (1996). Some ethnopharmacological notes on African hallucinogens. Journal of Ethnopharmacology.
Johnson, Gold & Gleaton (1996). Hallucinogen and other illicit drug uses increases in the USA. Biological Psychiatry.
Marek & Aghajanian (1996). LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. The Journal of Pharmacology and Experimental Therapeutics.
Monte et al. (1996). Dihydrobenzofuran analogues of hallucinogens: Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups 2.
Penington (1996). Actions of methoxylated amphetamine hallucinogens on serotonergic neurons of the brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry.
Baker & Taylor (1997). Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Pharmacology, Biochemistry, and Behavior.
Eisner (1997). Set, setting, and matrix. Journal of Psychoactive Drugs.
Farrell (1997). Horizon: Psychedelic Science. British Medical Journal.
Lerner et al. (1997). Naltrexone treatment of hallucinogen persisting perception disorder. The American Journal of Psychiatry.
Morehead (1997). Exacerbation of hallucinogen-persisting perception disorder with risperidone. Journal of Clinical Psychopharmacology.
Moreno & Delgado (1997). Hallucinogen-induced relief of obsessions and compulsions. The American Journal of Psychiatry.
Novak (1997). LSD before Leary: Sidney Cohen's critique of 1950s psychedelic drug research. Isis.
Aghajanian & Marek (1998). Hallucinogen-induced EPSPs in neocortical pyramidal cells. Biological Psychiatry.
Alcántara (1998). Is there a role for the alpha2 antagonism in the exacerbation of hallucinogen-persisting perception disorder with risperidone? Journal of Clinical Psychopharmacology.
Delgado & Moreno (1998). Hallucinogens, serotonin and obsessive-compulsive disorder. Journal of Psychoactive Drugs.
Gouzoulis-Mayfrank et al. (1998). History, rationale and potential of human experimental hallucinogenic drug research in psychiatry. Pharmacopsychiatry.
Grob, Greer & Mangini (1998). Editor's introduction: Hallucinogens at the turn of the century. Journal of Psychoactive Drugs.
Krebs-Thomson, Paulus & Geyer (1998). Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology.
Lerner et al. (1998). Clonidine treatment for hallucinogen persisting perception disorder. The American journal of psychiatry.
Liff (1998). Adding the spiritual to the biopsychosocial framework. Contemporary Psychology.
Macdonald et al. (1998). Adolescent transition and the use of hallucinogens: A subcultural analysis. British Journal of Psychotherapy.
Mangini (1998). Treatment of alcoholism using psychedelic drugs: a review of the program of research. Journal of Psychoactive Drugs.
Marek & Aghajanian (1998). Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action. Drug and Alcohol Dependence.
Novak (1998). Second thoughts on psychedelic drugs. Endeavour.
Schechter (1998). MDMA-like stimulus effects of hallucinogens in male fawn–hooded rats. Pharmacology, Biochemistry and Behavior.
Smith & Tart (1998). Cosmic consciousness experience and psychedelic experiences: A first person comparison. Journal of Consciousness Studies.
Aghajanian & Marek (1999). Serotonin and hallucinogens. Neuropsychopharmacology.
Al-Assmar (1999). The seeds of the Hawaiian baby woodrose are a powerful hallucinogen. Archives of Internal Medicine.
Baker (1999). Divine inspiration? An examination of the impact of hallucinogens on the production of imagery among some south American populations. Journal for the Scientific Study of Religion.
Blair et al. (1999). Thieno[3,2- b ]- and thieno[2,3- b ]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N , N -dimethyltryptamine. Journal of Medicinal Chemistry.
Halpern & Pope (1999). Do hallucinogens cause residual neuropsychological toxicity? Drug and Alcohol Dependence.
Jenson & Howard (1999). Hallucinogen use among juvenile probationers: prevalence and characteristics.
Kendler, Karkowski & Prescott (1999). Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins. Acta Psychiatrica Scandinavica.
Löhrer & Kaiser (1999). [Biological hallucinogens. New patterns of substance abuse in young addicts?] Der Nervenarz.
Perrine (1999). Hallucinogens and obsessive-compulsive disorder. The American Journal of Psychiatry.
Roberts (1999). Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness. Advances in Mind-Body Medicine.
Stolaroff (1999). Are psychedelics useful in the practice of Buddhism? Journal of Humanistic Psychology.
Ten Berge (1999). Breakdown or breakthrough? A history of European research into drugs and creativity. The Journal of Creative Behavior.
Van Etton (1999). Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin. Drug and Alcohol Dependence.
Winter et al. (1999). Serotonergic receptor subtypes and hallucinogen-induced stimulus control. Pharmacology, Biochemistry and Behavior.
Winter et al. (1999). The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens. Pharmacology, Biochemistry and Behavior.
Kafkalides (2000). Knowledge as an emotional and intellectual realization of the unconscious. Gnosiology, psychedelic drugs and prenatal experiences. Neuroendocrinology Letters.
Kjellgren & Norlander (2000). Psychedelic drugs: A study of drug-induced experiences obtained by illegal drug users in relation to Stanislav Grof's model of altered states of consciousness. Imagination, Cognition and Personality.
Lerner et al. (2000). LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. International Clinical Psychopharmacology.
Long et al. (2000). The use of henbane (Hyoscyamus niger L.) as a hallucinogen at Neolithic 'ritual' sites: A re-evaluation. Antiquity.